Sun Pharma Fertigyn 10000IU

Human Chorionic Gonadotropin is a potent polypeptide hormone that is present in pregnant women. It is utilized therapeutically, most frequently for: Cryptorchidism, Female Infertility, Hypogonadism (Low Testosterone), and Weight Loss.

HCG is commonly employed by many anabolic steroid users as a supplementary agent during or after the discontinuation of steroid use. When taking anabolic steroids, supplementation aims to counteract the hormonal suppression caused by steroid usage. Post-use, it is used to enhance or expedite recovery.

In contemporary times, one of HCG's main applications is as a dietary aid. The HCG diet has gained popularity in Western medicine, yet its overall effectiveness is a topic of significant debate. Both the American Medical Association and the American Society of Bariatric Physicians have criticized the HCG diet, asserting that any weight loss is primarily due to the starvation that accompanies such a regimen. The diet typically restricts caloric intake to around 500 calories per day. Analyzing HCG’s impact on metabolism reveals no stimulation of the thyroid, no beta-2 agonist activity, no appetite suppression, and it lacks traits associated with thermogenic or fat-burning agents. Nevertheless, numerous physicians have reported positive outcomes with the HCG diet; however, the starvation aspect raises concerns since it cannot be considered a healthy long-term approach. Currently, there is no solid evidence proving that HCG itself facilitates weight loss beyond what would occur with starvation alone. The discussion surrounding this diet is likely to continue for many years ahead.

The effects of HCG on anabolic steroid users can be classified into two categories: post-cycle therapy (PCT) use and on-cycle use. Anabolic steroids suppress natural testosterone production significantly, with the degree of suppression dependent on the specific steroids and doses involved. After steroid use ceases, natural testosterone production gradually resumes on its own, provided there was no pre-existing low testosterone issue or significant damage to the HPTA caused by improper steroid use. Although production restarts, the process is slow, and users may experience low testosterone levels, leading to symptoms that can hinder muscle mass retention as cortisol levels rise. For this reason, many steroid users adopt a PCT strategy to facilitate recovery. This helps accelerate the recovery process, ensuring sufficient testosterone for normal bodily function while levels gradually rise.

There are various PCT plans available, typically including SERM’s like Nolvadex (Tamoxifen Citrate) and/or Clomid (Clomiphene Citrate). Many have found that starting a PCT protocol with HCG prior to SERM administration enhances overall recovery. Essentially, HCG acts like LH, preparing the body for subsequent SERM therapy to yield a more effective recuperation.

Another positive effect of HCG for anabolic steroid users is its use during active cycles. Steroid use can lead to testicular atrophy due to suppressed natural testosterone production. By supplementing with HCG during this period, users can maintain testicular size. While this primarily serves a cosmetic purpose without strategic advantage, there is a potential benefit: maintaining exogenous LH levels may facilitate recovery after steroid cessation. However, a significant risk exists; the body can readily become reliant on HCG for its LH needs. Unlike anabolic steroids, HCG can lead to dependency. This poses little concern for those with low testosterone issues using HCG, but for others, careful regulation and monitoring of HCG use during cycles is imperative to prevent LH dependency. Many anabolic steroid users have caused more harm to their bodies through excessive HCG use than from steroid use itself. Responsible use of HCG during cycles can be beneficial for smoother recovery, but must be managed cautiously regardless of the context—during cycles or as an initiation for PCT.

For anabolic steroid users taking HCG during their cycle, a common dose is 250 IU every 4-5 days. This amount is generally sufficient to achieve the desired results without risking future natural testosterone production.

The final HCG dosing strategy pertains to PCT and includes two main protocols. The first suggests administering 1,500-4,000 IU every 3-4 days for 2-3 weeks, after which SERM therapy will commence. The second, potentially more efficient method is to give HCG daily at 500-1,000 IU for ten consecutive days, followed by SERM therapy.

Timing is crucial when using HCG during PCT. If your steroid cycle concludes with large ester-based steroids, HCG therapy should start ten days after your last injection, followed by SERM therapy once HCG is finished. Conversely, if your cycle ends with all small ester-based steroids, HCG therapy will begin three days after your last injection, leading into SERM therapy once HCG use is complete.